本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Anaptysbio Inc

53.87
-1.2900-2.34%
盤後53.870.00000.00%19:30 EDT
成交量:33.62萬
成交額:1,832.90萬
市值:15.95億
市盈率:-59.54
高:56.32
開:55.43
低:53.75
收:55.16
52周最高:73.30
52周最低:17.11
股本:2,960.85萬
流通股本:2,104.51萬
量比:0.55
換手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-0.9047
每股收益(LYR):-0.4601
淨資產收益率:-114.55%
總資產收益率:6.78%
市淨率:125.13
市盈率(LYR):-117.08

資料載入中...

2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

重要事件披露

Form 8-K - Current report
2026/04/29

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/24

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/04/20

重要事件披露

Form 8-K - Current report
2026/03/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities